These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6537285

  • 1. [Clozapine and agranulocytosis].
    Xu SH.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):271-2. PubMed ID: 6537285
    [No Abstract] [Full Text] [Related]

  • 2. [Frequent cases of agranulocytosis due to clozapin (leponex) in eastern Switzerland].
    Jungi WF, Fischer J, Senn HJ, Hartlapp J, Pöldinger W, Kunz H, Krupp P.
    Schweiz Med Wochenschr; 1977 Dec 10; 107(49):1861-4. PubMed ID: 929152
    [Abstract] [Full Text] [Related]

  • 3. [Remarks on clozapine].
    Steinbauer G, Diehl LW.
    Nervenarzt; 1980 Jun 10; 51(6):373-4. PubMed ID: 7453889
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
    Lieberman JA, Johns CA, Kane JM, Rai K, Pisciotta AV, Saltz BL, Howard A.
    J Clin Psychiatry; 1988 Jul 10; 49(7):271-7. PubMed ID: 3391979
    [Abstract] [Full Text] [Related]

  • 7. Clozapine and agranulocytosis.
    Senn HJ, Jungi WF, Kunz H, Pöldinger W.
    Lancet; 1977 Mar 05; 1(8010):547. PubMed ID: 65644
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Hematological complications caused by clozapine (Leponex)].
    Palva I.
    Duodecim; 1976 Mar 05; 92(1):1-2. PubMed ID: 1248428
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Letter: Clozapine and agranulocytosis.
    Griffith RW, Saameli K.
    Lancet; 1975 Oct 04; 2(7936):657. PubMed ID: 52022
    [No Abstract] [Full Text] [Related]

  • 13. Clozapine-induced agranulocytosis: a situation report up to August 1976.
    Anderman B, Griffith RW.
    Eur J Clin Pharmacol; 1977 Mar 11; 11(3):199-201. PubMed ID: 852497
    [Abstract] [Full Text] [Related]

  • 14. [The most common complications in neuroleptic therapy. A case report].
    Preradović M.
    Vojnosanit Pregl; 1981 Mar 11; 38(3):211-2. PubMed ID: 7281540
    [No Abstract] [Full Text] [Related]

  • 15. [Acute bone marrow and liver damage during treatment with clozapine].
    Brodowski L, Matusewicz W, Urbańska-Ryś H, Krykowski E.
    Pol Tyg Lek; 1984 May 21; 39(21):721-2. PubMed ID: 6483677
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FDA's position on the clozaril patient management system.
    Peck CC.
    Hosp Community Psychiatry; 1990 Aug 21; 41(8):876-7. PubMed ID: 2401475
    [No Abstract] [Full Text] [Related]

  • 18. Leponex--associated granulocytopenia: a review of the situation.
    Krupp P, Barnes P.
    Psychopharmacology (Berl); 1989 Aug 21; 99 Suppl():S118-21. PubMed ID: 2682727
    [No Abstract] [Full Text] [Related]

  • 19. Notes from a state mental health directors' meeting on clozapine.
    Salzman C.
    Hosp Community Psychiatry; 1990 Aug 21; 41(8):838-9, 842. PubMed ID: 2401474
    [No Abstract] [Full Text] [Related]

  • 20. Proceedings: The relation between the clinical effect of clozapine and the incidence of side effects.
    Marecek P, Dolezalová V, Faltus F.
    Act Nerv Super (Praha); 1975 Aug 21; 17(4):221-2. PubMed ID: 1221762
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.